Toxoplasmosis Gondii Infection and Diabetes Mellitus Type 2 Treated by Using Autologous Peripheral Blood Stem Cells a Unique Case Report of a Caucasian 83 Year Old Lady
- 30 August 2015
- journal article
- Published by Biomedical Research and Therapy in Biomedical Research and Therapy
- Vol. 2 (8), 1-8
- https://doi.org/10.7603/s40730-015-0019-8
Abstract
Introduction: Toxoplasma gondii is an intracellular protozoan responsible for up to one-third of the worlds population infestation. Diabetes is one of the most silent and threatening disease of the modern time it is constantly in- creasing in both industrialized and developing countries. This is a case of clinically importance for two reason, firstly it will help clinicians save a broad differential diagnosis when attending to evaluate analogous cases and secondly, it may confirm the role of autologous peripheral blood stem cells (PB-SCs) in enhancing auto-immune response against parasitic infection and in regulating insulin uptake in diabetes mellitus type 2 (DM2). Case presentation: We present a unique case of 83- year-old woman from Argentina presenting with a widespread erythema and urticaria for 5 months and DM2 as underly- ing condition. She was initially diagnosed with unspecific skin auto-immune disorder. By the time of visit she was com- plaining of constant diarrhea-constipation and general mental and physical fatigue. Conclusion: This case illustrates that toxoplasmosis can present with just simple disseminated and generalized skin erythema with severe itching and, thus can be confused with similar infectious disease such as Epstein-Barr virus (EBV), cytomegalovirus, cat scratch disease or leishmaniasis. The report emphasizes the need of correct diagnostic procedure in confusing cases, and may help to increase the awareness about the identification of this disease. This case may open to the possibility of a different approach and me- thodology in treatment T gondii and DM2 through the use of PB-SCs. [Biomed Res Ther 2015; 2(8.000): 339-346Keywords
This publication has 31 references indexed in Scilit:
- Toxoplasmosis in a patient who was immunocompetent: a case reportJournal of Medical Case Reports, 2011
- Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes MellitusThe International Journal of Cell Cloning, 2011
- Mesenchymal Stem Cells Enhance Allogeneic Islet Engraftment in Nonhuman PrimatesDiabetes, 2010
- Efficacy of Autologous Bone Marrow–Derived Stem Cell Transplantation in Patients With Type 2 Diabetes MellitusStem Cells and Development, 2009
- Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesisAutoimmunity, 2009
- Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitroDifferentiation, 2009
- Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9Diabetes, 2009
- Autologous peripheral blood stem cell transplantation for lung cancerBest Practice & Research Clinical Haematology, 1999
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1995
- Toxoplasmosis in a Patient with Common Variable ImmunodeficiencyThe American Journal of the Medical Sciences, 1984